YKYotaro Kodaira

Yotaro Kodaira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yotaro Kodaira has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Aki Yamaguchi

    Department of Bacteriology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa 920-8640, Japan

    1 shared publication
  • Daisuke Motooka

    Department of Infection Metagenomics, Bioinformatics Center, Research Institute for Microbial Diseases (RIMD), The University of Osaka, Suita, Osaka, 565-0871, Japan

    1 shared publication
  • Daisuke Takahashi

    Division of Biochemistry, Faculty of Pharmacy, Keio University, Tokyo 105-8512, Japan

    1 shared publication
  • Hiroki Toriumi

    Division of Biochemistry, Faculty of Pharmacy, Keio University, Tokyo 105-8512, Japan

    1 shared publication
  • Jiayue Yang

    Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan

    1 shared publication
  • Kanon Iwata

    Department of Bacteriology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa 920-8640, Japan

    1 shared publication

Latest Publications

  • Open Access

    Acquisition of Stickland-metabolizing bacteria during infancy prevents Clostridium botulinum infection

    by Nobuhide Kobayashi, Yotaro Kodaira, Jiayue Yang, Takuhiro Matsumura, Aki Yamaguchi, Yuta Arai, Daisuke Takahashi, Hiroki Toriumi, Seiga Komiyama, Kanon Iwata, et al.

    The mechanisms by which maturation of the infant gut microbiota promotes resistance to pathogen colonization remain poorly understood. Infant botulism, a potentially fatal disease caused by intestinal colonization by Clostridium botulinum, provides a striking example of age-dependent susceptibility to infection. Although the gut microbiota has long been implicated in protection against C. botulinum, the responsible bacterial species and underlying mechanisms have yet to be elucidated. Here, we show that acquisition of Stickland-metabolizing Clostridia during infant gut microbiota maturation confers resistance to C. botulinum colonization through competition for shared amino-acid-dependent nutritional niches. In human fecal microbiota-transplanted mice, longitudinally collected infant microbiotas exhibited a clear transition from susceptibility to resistance. Intestinal metabolomic analysis identified 5-aminovalerate as a hallmark metabolite of the resistant microbiota, implicating Stickland metabolism, an amino acid metabolic pathway also utilized by C. botulinum. Guided by this finding, metagenomic analysis revealed enrichment of Stickland-metabolizing Clostridia in resistant microbiotas, including Clostridioides difficile, a bacterium frequently carried by healthy infants. Intestinal metabolic signatures of C. botulinum and infant-derived Stickland-metabolizing Clostridia suggested competition for shared amino-acid-dependent nutritional niches. Consistent with this model, C. difficile suppressed C. botulinum expansion through nutrient competition. Together, these findings identify nutritional niche competition as a mechanism by which microbiota maturation promotes resistance to C. botulinum colonization. This work demonstrates how acquisition of specific microbial metabolic functions during early life can shift the gut microbiota from a susceptible to a resistant state.